Skip to main content
Peter Izmirly, MD, Rheumatology, New York, NY, Veterans Affairs New York Harbor Healthcare System

PeterM.IzmirlyMD

Rheumatology New York, NY

Assistant Professor, Medicine, New York University School of Medicine

Dr. Izmirly is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Izmirly's full profile

Already have an account?

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Rheumatology, 2004 - 2007
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 2001 - 2004
  • New York University School of Medicine
    New York University School of MedicineClass of 2001

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2002 - 2026
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow (FACR) American College of Rheumatology

Publications & Presentations

PubMed

Journal Articles

  • A Prospective International Study on Adherence to Treatment in 305 Patients with Flaring SLE: Assessment by Drug Levels and Self‐Administered Questionnaires  
    Peter Izmirly, Michelle Petri, Meenakshi Jolly, Jill Buyon, Clinical Pharmacology & Therapeutics

Lectures

  • Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers 
    76th Annual Scienific Meeting, Washington, DC, USA

Authored Content

  • Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive MothersJuly 2020
  • Tubulointerstitial Damage Predicts End Stage Renal Disease in Lupus Nephritis with Preserved to Moderately Impaired Renal Function: A Retrospective Cohort StudyFebruary 2018

Press Mentions

  • Patients with Lupus Benefit from COVID-19 Vaccine Booster – ScienceDaily
    Patients with Lupus Benefit from COVID-19 Vaccine Booster – ScienceDailyJuly 13th, 2022
  • COVID-19 Booster Vaccine Beneficial for Lupus Patients: Study
    COVID-19 Booster Vaccine Beneficial for Lupus Patients: StudyJuly 13th, 2022
  • NYU Langone Joins NIH-Sponsored Program as Leading Center to Discover New Targets for Autoimmune, Inflammatory Diseases
    NYU Langone Joins NIH-Sponsored Program as Leading Center to Discover New Targets for Autoimmune, Inflammatory DiseasesMarch 30th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations